![](https://danskbiotek.dk/wp-content/uploads/2016/09/symphogen.png)
Symphogen presents promising results from a randomized Phase 2 study with Sym004 01 September 2017
Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer Symphogen... Read more
Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer Symphogen... Read more
Pan-Nordic mentor network NOME provides Nordic life science start-ups with the opportunity to present... Read more
Interesting EU project PERMIDES provides innovation vouchers for biopharma SMEs valued up to 60,000... Read more
Området for Personlig Medicin har potentialet til at blive et vigtigt dansk forskningsområde med lovende... Read more
Mens sommerferien nu er i gang i det meste af Danmark er Udenrigsministeriet aktuelt ved at lægge sidste... Read more
Join Precision NanoSystems for its second annual nanomedicines symposium, entitled Nanomedicines: enabling... Read more
The FDA grants Y-mAbs Therapeutics, Inc. a Rare Pediatric Disease Designation for hu3F8 for the treatment... Read more
The Most Innovative European Biotech SME Award is a unique annual initiative recognizing biotech innovation... Read more
The European Biotech Week aims to facilitate a genuine dialogue about the science, the people, the companies... Read more